Molecular imaging of tumor microenvironment: Challenges and perspectives (547 views visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 249-258.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article, Review,
Impact factor: 1.724, 5-year impact factor Impact factor a 5 anni: 1.952
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-77958610812&partnerID=40&md5=2b443643bb9141a61702f320d72b25a7
Keywords Parole chiave: Extracellular Matrix, Matrix Metalloproteinases, Molecular Imaging, 10 Tetraazacyclododecane 1, 10 Tetraacetic Acid, 2 (n Benzyl 4 Methoxybenzenesulfonamido) N Hydroxy 3 Methylbutanamide, Cgs 27023 A, Copper 64, Cyclin D1, Cytokine, Fibroblast Growth Factor, Fibronectin, Gadolinium, Gelatinase A, Iodine 124, Messenger Rna, Nanoparticle, Scatter Factor, Somatomedin, Unclassified Drug, Urokinase, Urokinase Receptor, Arthritis, Breast Adenocarcinoma, Cancer Cell, Cell Infiltration, Cell Interaction, Enzyme Synthesis, Extracellular Fluid, Glycolysis, Host Cell, Human, Hypoxia, Immunocompetent Cell, Kaposi Sarcoma, Molecular Probe, Nonhuman, Nuclear Magnetic Resonance Imaging, Nuclear Magnetic Resonance Spectroscopy, Phenotype, Review, Tumor Microenvironment, Animals, Hydrogen-Ion Concentration, Extracellular Matrix Physiology, Matrix Metalloproteinases Metabolism, Tumor Microenvironment Physiology, Diagnostic Imaging, Drug Delivery System, Editorial, Genetic Procedures, Nuclear Medicine, Molecular Probe Techniques, Angiogenesis, Carcinogenesis, Disease Course, Positron Emission Tomography, Treatment Response, Tumor Growth, Neovascularization, Pathologic,
Affiliations Affiliazioni:
*** IBB - CNR ***
Department of Biomorphological and Functional Sciences, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy
Institute of Biostructures and Bioimages, National Research Council, Naples, Italy
Centre of Excellence of Neurodegenerative Diseases, Institute of Pharmacological Sciences, University of Milan, Milan, Italy.
Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institute of Health (NIH), Bethesda, MD, United States
References Riferimenti:
Bhowmick, N.A., Moses, H.L., Tumor-stroma interactions (2005) Curr Opin Genet Dev, 15, pp. 97-10
Mueller, M.M., Fusenig, N.E., Friends or foes - Bipolar effects of the tumour stroma in cancer (2004) Nat Rev Cancer, 4, pp. 839-849
Joyce, J.A., Pollard, J.W., Microenvironmental regulation of metastasis (2009) Nat Rev Cancer, 9, pp. 239-252
Pietras, K., Ostman, A., Hallmarks of cancer: Interactions with the tumor stroma (2010) Exp Cell Res, , doi:10.10l6/j.yexcr.2010.02.045
Cretu, A., Brooks, P.C., Impact of the non-cellular tumor microenvironment on metastasis: Potential therapeutic and imaging opportunities (2007) J Cell Physiol, 213, pp. 391-402
Dang, C.V., Kim, J.W., Gao, P., Yustein, J., The interplay between MYC and HIF in cancer (2008) Nat Rev Cancer, 8, pp. 51-56
Gatenby, R.A., Gillies, R.J., A microenvironmental model of carcinogenesis (2008) Nat Rev Cancer, 8, pp. 56-61
Denko, N.C., Hypoxia, HIF1 and glucose metabolism in the solid tumour (2008) Nat Rev Cancer, 8, pp. 705-713
Mason, R.B., Zhao, D., Pecheco-Torres, J., Cui, W., Kodibagkar, V.D., Gulaka, P.K., Multimodality imaging of hypoxia in preclinical settings (2010) Q J Nucl Med Mol Imaging, 54, pp. 259-280
Vander Heiden, M.G., Cantley, L.C., Thompson, C.B., Understanding the Warburg effect: The metabolic requirements of cell proliferation (2009) Science, 324, pp. 1029-1033
Gillies, R.J., Robey, I., Gatenby, R.A., Causes and consequences of increased glucose metabolism of cancers (2008) J Nucl Med, 49 (SUPPL. 2), pp. 24S-42S
Plathow, C., Weber, W.A., Tumor cell metabolism imaging (2008) J Nucl Med, 49 (SUPPL. 2), pp. 43S-63S
Meads, M.B., Gatenby, R.A., Dalton, W.S., Environment-mediated drug resistance: A major contributor to minimal residual disease (2009) Nat Rev Cancer, 9, pp. 665-674
Stubbs, M., McSheehy, P.M., Griffiths, J.R., Causes and consequences of acidic pH in tumors: A magnetic resonance study (1999) Adv Enzyme Regul, 39, pp. 13-30
Raghunand, N., Gillies, R.J., pH and chemotherapy (2001) Novartis Found Symp, 240, pp. 199-211. , discussion 65-8
Rajendran, J.G., Krohn, K.A., Imaging hypoxia and angiogenesis in tumors (2005) Radiol Clin North Am, 43, pp. 169-187
Griffiths, J.R., Stevens, A.N., Iles, R.A., Gordon, R.E., Shaw, D., 31P-NMR investigation of solid tumours in the living rat (1981) Biosci Rep, 1, pp. 319-325
Evanochko, W.T., Ng, T.C., Lilly, M.B., Lawson, A.J., Corbett, T.H., Durant, J.R., In vivo 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia (1983) Proc Natl Acad Sci U S A, 80, pp. 334-338
Griffiths, J.R., Are cancer cells acidic? (1991) Br J Cancer, 64, pp. 425-427
Gillies, R.J., Liu, Z., Bhujwalla, Z., 31P-MRS measurements of extra-cellular pH of tumors using 3-aminopropylphosphonate (1994) Am J Physiol, 267, pp. C195-203
Gil, S., Zaderenzo, P., Cruz, F., Cerdan, S., Ballesteros, P., Imidazol-1-ylalkanoic acids as extrinsic 1H NMR probes for the determination of intracellular pH, extracellular pH and cell volume (1994) Bioorg Med Chem, 2, pp. 305-314
Zhou, J., Payen, J.F., Wilson, D.A., Traystman, R.J., Van Zijl, P.C., Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI (2003) Nat Med, 9, pp. 1085-1090
Aime, S., Barge, A., Delli Castelli, D., Fedeli, F., Mortillaro, A., Nielsen, F.U., Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications (2002) Magn Reson Med, 47, pp. 639-648
Garcia-Martin, M.L., Martinez, G.V., Raghunand, N., Sherry, A.D., Zhang, S., Gillies, R.J., High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity (2006) Magn Reson Med, 55, pp. 309-315
Gallagher, F.A., Kettunen, M.I., Day, S.E., Hu, D.E., Ardenkjaer-Larsen, J.H., Zandt, R., Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate (2008) Nature, 453, pp. 940-943
Andreev, O.A., Dupuy, A.D., Segala, M., Sandugu, S., Serra, D.A., Chichester, C.O., Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo (2007) Proc Natl Acad Sci U S A, 104, pp. 7893-7898
Urano, Y., Asanuma, D., Hama, Y., Koyama, Y., Barrett, T., Kamiya, M., Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes (2009) Nat Med, 15, pp. 104-109
Vavere, A.L., Biddlecombe, G.B., Spees, W.M., Garbow, J.R., Wijesinghe, D., Andreev, O.A., A novel technology for the imaging of acidic prostate tumors by positron emission tomography (2009) Cancer Res, 69, pp. 4510-4516
Egeblad, M., Werb, Z., New functions for the matrix metalloproteinases in cancer progression (2002) Nat Rev Cancer, 2, pp. 161-174
Smith, H.W., Marshall, C.J., Regulation of cell signalling by uPAR (2010) Nat Rev Mol Cell Biol, 11, pp. 23-36
Bremer, C., Tung, C.H., Weissleder, R., In vivo molecular target assessment of matrix metalloproteinase inhibition (2001) Nat Med, 7, pp. 743-748
Scherer, R.L., VanSaun, M.N., McIntyre, J.O., Matrisian, L.M., Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon (2008) Mol Imaging, 7, pp. 118-131
Jiang, T., Olson, E.S., Nguyen, Q.T., Roy, M., Jennings, P.A., Tsien, R.Y., Tumor imaging by means of proteolytic activation of cell-penetrating peptides (2004) Proc Natl Acad Sci U S A, 101, pp. 17867-17872
Olson, E.S., Aguilera, T.A., Jiang, T., Ellies, L.G., Nguyen, Q.T., Wong, E.H., In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer (2009) Integr Biol, 1, pp. 382-393. , Camb
Breyholz, H.J., Wagner, S., Levkau, B., Schober, O., Schafers, M., Kopka, K., A 18F-radiolabeled analogue of CGS 27023A as a potential agent for assessment of matrix-metalloproteinase activity in vivo (2007) Q J Nucl Med Mol Imaging, 51, pp. 24-32
Zheng, Q.H., Fei, X., Liu, X., Wang, J.Q., Stone, K.L., Martinez, T.D., Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4′-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4′-[11C]methoxyphenyl)sulfonyl]benzylamino]- 3-methylbut anamide (2004) Nucl Med Biol, 31, pp. 77-85
Kopka, K., Breyholz, H.J., Wagner, S., Uw, M.P., Riemann, B., Schroer, S., Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo (2004) Nucl Med Biol, 31, pp. 257-267
Schafers, M., Riemann, B., Kopka, K., Breyholz, H.J., Wagner, S., Schafers, K.P., Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo (2004) Circulation, 109, pp. 2554-2559
Wagner, S., Breyholz, H.J., Holtke, C., Faust, A., Schober, O., Schafers, M., A new 18F-labelled derivative of the MMP inhibitor CGS 27023A for PET: Radiosynthesis and initial small-animal PET studies (2009) Appl Radiat Isot, 67, pp. 606-610
Kulasegaram, R., Giersing, B., Page, C.J., Blower, P.J., Williamson, R.A., Peters, B.S., In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection (2001) Eur J Nucl Med, 28, pp. 756-761
Lepage, M., Dow, W.C., Melchior, M., You, Y., Fingleton, B., Quarles, C.C., Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch (2007) Mol Imaging, 6, pp. 393-403
Lebel, R., Jastrzebska, B., Therriault, H., Cournoyer, M.M., McIntyre, J.O., Escher, E., Novel solubility-switchable MRI agent allows the noninvasive detection of matrix metalloproteinase-2 activity in vivo in a mouse model (2008) Magn Reson Med, 60, pp. 1056-1065
Olson, E.S., Jiang, T., Aguilera, T.A., Nguyen, Q.T., Ellies, L.G., Scadeng, M., Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases (2010) Proc Natl Acad Sci U S A, 107, pp. 4311-4316
D'Alessio, S., Blasi, F., The urokinase receptor as an entertainer of signal transduction (2009) Front Biosci, 14, pp. 4575-4587
Dass, K., Ahmad, A., Azmi, A.S., Sarkar, S.H., Sarkar, F.H., Evolving role of uPA/uPAR system in human cancers (2008) Cancer Treat Rev, 34, pp. 122-136
Del Vecchio, S., Stoppelli, M.P., Carriero, M.V., Fonti, R., Massa, O., Li, P.Y., Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels (1993) Cancer Res, 53, pp. 3198-3206
Zannetti, A., Del Vecchio, S., Carriero, M.V., Fonti, R., Franco, P., Botti, G., Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma (2000) Cancer Res, 60, pp. 1546-1551
Shariat, S.F., Roehrborn, C.G., McConnell, J.D., Park, S., Alam, N., Wheeler, T.M., Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis (2007) J Clin Oncol, 25, pp. 349-355
Stephens, R.W., Nielsen, H.J., Christensen, I.J., Thorlacius-Ussing, O., Sorensen, S., Dano, K., Plasma urokinase receptor levels in patients with colorectal cancer: Relationship to prognosis (1999) J Natl Cancer Inst, 91, pp. 869-874
Li, Z.B., Niu, G., Wang, H., He, L., Yang, L., Ploug, M., Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET (2008) Clin Cancer Res, 14, pp. 4758-4766
Yang, L., Peng, X.H., Wang, Y.A., Wang, X., Cao, Z., Ni, C., Receptor-targeted nanoparticles for in vivo imaging of breast cancer (2009) Clin Cancer Res, 15, pp. 4722-4732
Santimaria, M., Moscatelli, G., Viale, G.L., Giovannoni, L., Neri, G., Viti, F., Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer (2003) Clin Cancer Res, 9, pp. 571-579
Berndorff, D., Borkowski, S., Moosmayer, D., Viti, F., Muller-Tiemann, B., Sieger, S., Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments (2006) J Nucl Med, 47, pp. 1707-1716
Tijink, B.M., Perk, L.R., Budde, M., Stigter-van Walsum, M., Visser, G.W., Kloet, R.W., (124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy (2009) Eur J Nucl Med Mol Imaging, 36, pp. 1235-1244
Rossin, R., Berndorff, D., Friebe, M., Dinkelborg, L.M., Welch, M.J., Small-animal PET of tumor angiogenesis using a (76)Br-labeled human recombinant antibody fragment to the ED-B domain of fibronectin (2007) J Nucl Med, 48, pp. 1172-1179
Orend, G., Chiquet-Ehrismann, R., Tenascin-C induced signaling in cancer (2006) Cancer Lett, 244, pp. 143-163
Herold-Mende, C., Mueller, M.M., Bonsanto, M.M., Schmitt, H.P., Kunze, S., Steiner, H.H., Clinical impact and functional aspects of tenascin-C expression during glioma progression (2002) Int J Cancer, 98, pp. 362-369
Riva, P., Franceschi, G., Riva, N., Casi, M., Santimaria, M., Adamo, M., Role of nuclear medicine in the treatment of malignant gliomas: The locoregional radioimmunotherapy approach (2000) Eur J Nucl Med, 27, pp. 601-609
Akabani, G., Reardon, D.A., Coleman, R.E., Wong, T.Z., Metzler, S.D., Bowsher, J.E., Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: A phase II study (2005) J Nucl Med, 46, pp. 1042-1051
Zalutsky, M.R., Reardon, D.A., Akabani, G., Coleman, R.E., Friedman, A.H., Friedman, H.S., Clinical experience with alpha-particle emitting 211At: Treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6 (2008) J Nucl Med, 49, pp. 30-38
Paganelli, G., Grana, C., Chinol, M., Cremonesi, M., De Cicco, C., De Braud, F., Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin (1999) Eur J Nucl Med, 26, pp. 348-357
Hicke, B.J., Stephens, A.W., Gould, T., Chang, Y.F., Lynott, C.K., Heil, J., Tumor targeting by an aptamer (2006) J Nucl Med, 47, pp. 668-678
Zhu, L., Niu, G., Fang, X., Chen, X., Preclinical molercular imaging of tumor angiogenesis (2010) Q J Nucl Med Mol Imaging, 54, pp. 291-308
Hay, R.V., Cao, B., Skinner, R.S., Su, Y., Zhao, P., Gustafson, M.F., Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek) (2005) Clin Cancer Res, 11, pp. 7064s-9s
Perk, L.R., Stigter-van Walsum, M., Visser, G.W., Kloet, R.W., Vosjan, M.J., Leemans, C.R., Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30 (2008) Eur J Nucl Med Mol Imaging, 35, pp. 1857-1867
Shaharabany, M., Abramovitch, R., Kushnir, T., Tsarfaty, G., Ravid-Megido, M., Horev, J., In vivo molecular imaging of met tyrosine kinase growth factor receptor activity in normal organs and breast tumors (2001) Cancer Res, 61, pp. 4873-4878
Cornelissen, B., McLarty, K., Kersemans, V., Reilly, R.M., The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin) (2008) Nucl Med Biol, 35, pp. 645-653
Tian, X., Aruva, M.R., Zhang, K., Shanthly, N., Cardi, C.A., Thakur, M.L., PET imaging of CCND1 mRNA in human MCF7 estrogen receptor positive breast cancer xenografts with oncogene-specific [64Cu]chelator-peptide nucleic acid-IGF1 analog radiohybridization probes (2007) J Nucl Med, 48, pp. 1699-1707
Koizumi, K., Hojo, S., Akashi, T., Yasumoto, K., Saiki, I., Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response (2007) Cancer Sci, 98, pp. 1652-1658
Jacobson, O., Weiss, I.D., Szajek, L., Farber, J.M., Kiesewetter, D.O., 64Cu-AMD3100 - A novel imaging agent for targeting chemokine receptor CXCR4 (2009) Bioorg Med Chem, 17, pp. 1486-1493
Nimmagadda, S., Pullambhatla, M., Pomper, M.G., Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT (2009) J Nucl Med, 50, pp. 1124-1130
Bhowmick, N. A., Moses, H. L., Tumor-stroma interactions (2005) Curr Opin Genet Dev, 15, pp. 97-10
Mueller, M. M., Fusenig, N. E., Friends or foes - Bipolar effects of the tumour stroma in cancer (2004) Nat Rev Cancer, 4, pp. 839-849
Joyce, J. A., Pollard, J. W., Microenvironmental regulation of metastasis (2009) Nat Rev Cancer, 9, pp. 239-252
Dang, C. V., Kim, J. W., Gao, P., Yustein, J., The interplay between MYC and HIF in cancer (2008) Nat Rev Cancer, 8, pp. 51-56
Gatenby, R. A., Gillies, R. J., A microenvironmental model of carcinogenesis (2008) Nat Rev Cancer, 8, pp. 56-61
Denko, N. C., Hypoxia, HIF1 and glucose metabolism in the solid tumour (2008) Nat Rev Cancer, 8, pp. 705-713
Mason, R. B., Zhao, D., Pecheco-Torres, J., Cui, W., Kodibagkar, V. D., Gulaka, P. K., Multimodality imaging of hypoxia in preclinical settings (2010) Q J Nucl Med Mol Imaging, 54, pp. 259-280
Vander Heiden, M. G., Cantley, L. C., Thompson, C. B., Understanding the Warburg effect: The metabolic requirements of cell proliferation (2009) Science, 324, pp. 1029-1033
Gillies, R. J., Robey, I., Gatenby, R. A., Causes and consequences of increased glucose metabolism of cancers (2008) J Nucl Med, 49 (SUPPL. 2), pp. 24S-42S
Meads, M. B., Gatenby, R. A., Dalton, W. S., Environment-mediated drug resistance: A major contributor to minimal residual disease (2009) Nat Rev Cancer, 9, pp. 665-674
Rajendran, J. G., Krohn, K. A., Imaging hypoxia and angiogenesis in tumors (2005) Radiol Clin North Am, 43, pp. 169-187
Griffiths, J. R., Stevens, A. N., Iles, R. A., Gordon, R. E., Shaw, D., 31P-NMR investigation of solid tumours in the living rat (1981) Biosci Rep, 1, pp. 319-325
Evanochko, W. T., Ng, T. C., Lilly, M. B., Lawson, A. J., Corbett, T. H., Durant, J. R., In vivo 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia (1983) Proc Natl Acad Sci U S A, 80, pp. 334-338
Griffiths, J. R., Are cancer cells acidic? (1991) Br J Cancer, 64, pp. 425-427
Gillies, R. J., Liu, Z., Bhujwalla, Z., 31P-MRS measurements of extra-cellular pH of tumors using 3-aminopropylphosphonate (1994) Am J Physiol, 267, pp. C195-203
Zhou, J., Payen, J. F., Wilson, D. A., Traystman, R. J., Van Zijl, P. C., Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI (2003) Nat Med, 9, pp. 1085-1090
Garcia-Martin, M. L., Martinez, G. V., Raghunand, N., Sherry, A. D., Zhang, S., Gillies, R. J., High resolution pH (e) imaging of rat glioma using pH-dependent relaxivity (2006) Magn Reson Med, 55, pp. 309-315
Gallagher, F. A., Kettunen, M. I., Day, S. E., Hu, D. E., Ardenkjaer-Larsen, J. H., Zandt, R., Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate (2008) Nature, 453, pp. 940-943
Andreev, O. A., Dupuy, A. D., Segala, M., Sandugu, S., Serra, D. A., Chichester, C. O., Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo (2007) Proc Natl Acad Sci U S A, 104, pp. 7893-7898
Vavere, A. L., Biddlecombe, G. B., Spees, W. M., Garbow, J. R., Wijesinghe, D., Andreev, O. A., A novel technology for the imaging of acidic prostate tumors by positron emission tomography (2009) Cancer Res, 69, pp. 4510-4516
Smith, H. W., Marshall, C. J., Regulation of cell signalling by uPAR (2010) Nat Rev Mol Cell Biol, 11, pp. 23-36
Scherer, R. L., VanSaun, M. N., McIntyre, J. O., Matrisian, L. M., Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon (2008) Mol Imaging, 7, pp. 118-131
Olson, E. S., Aguilera, T. A., Jiang, T., Ellies, L. G., Nguyen, Q. T., Wong, E. H., In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer (2009) Integr Biol, 1, pp. 382-393. , Camb
Breyholz, H. J., Wagner, S., Levkau, B., Schober, O., Schafers, M., Kopka, K., A 18F-radiolabeled analogue of CGS 27023A as a potential agent for assessment of matrix-metalloproteinase activity in vivo (2007) Q J Nucl Med Mol Imaging, 51, pp. 24-32
Zheng, Q. H., Fei, X., Liu, X., Wang, J. Q., Stone, K. L., Martinez, T. D., Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S) -2- (4 - [11C] methoxybiphenyl-4-sulfonylamino) -3-methylbutyric acid and N-hydroxy- (R) -2- [[(4 - [11C] methoxyphenyl) sulfonyl] benzylamino] - 3-methylbut anamide (2004) Nucl Med Biol, 31, pp. 77-85
Lepage, M., Dow, W. C., Melchior, M., You, Y., Fingleton, B., Quarles, C. C., Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch (2007) Mol Imaging, 6, pp. 393-403
Olson, E. S., Jiang, T., Aguilera, T. A., Nguyen, Q. T., Ellies, L. G., Scadeng, M., Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases (2010) Proc Natl Acad Sci U S A, 107, pp. 4311-4316
Shariat, S. F., Roehrborn, C. G., McConnell, J. D., Park, S., Alam, N., Wheeler, T. M., Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis (2007) J Clin Oncol, 25, pp. 349-355
Stephens, R. W., Nielsen, H. J., Christensen, I. J., Thorlacius-Ussing, O., Sorensen, S., Dano, K., Plasma urokinase receptor levels in patients with colorectal cancer: Relationship to prognosis (1999) J Natl Cancer Inst, 91, pp. 869-874
Li, Z. B., Niu, G., Wang, H., He, L., Yang, L., Ploug, M., Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET (2008) Clin Cancer Res, 14, pp. 4758-4766
Yang, L., Peng, X. H., Wang, Y. A., Wang, X., Cao, Z., Ni, C., Receptor-targeted nanoparticles for in vivo imaging of breast cancer (2009) Clin Cancer Res, 15, pp. 4722-4732
Tijink, B. M., Perk, L. R., Budde, M., Stigter-van Walsum, M., Visser, G. W., Kloet, R. W., (124) I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131) I-L19-SIP radioimmunotherapy (2009) Eur J Nucl Med Mol Imaging, 36, pp. 1235-1244
Zalutsky, M. R., Reardon, D. A., Akabani, G., Coleman, R. E., Friedman, A. H., Friedman, H. S., Clinical experience with alpha-particle emitting 211At: Treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6 (2008) J Nucl Med, 49, pp. 30-38
Hicke, B. J., Stephens, A. W., Gould, T., Chang, Y. F., Lynott, C. K., Heil, J., Tumor targeting by an aptamer (2006) J Nucl Med, 47, pp. 668-678
Hay, R. V., Cao, B., Skinner, R. S., Su, Y., Zhao, P., Gustafson, M. F., Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek) (2005) Clin Cancer Res, 11, pp. 7064s-9s
Perk, L. R., Stigter-van Walsum, M., Visser, G. W., Kloet, R. W., Vosjan, M. J., Leemans, C. R., Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30 (2008) Eur J Nucl Med Mol Imaging, 35, pp. 1857-1867
Tian, X., Aruva, M. R., Zhang, K., Shanthly, N., Cardi, C. A., Thakur, M. L., PET imaging of CCND1 mRNA in human MCF7 estrogen receptor positive breast cancer xenografts with oncogene-specific [64Cu] chelator-peptide nucleic acid-IGF1 analog radiohybridization probes (2007) J Nucl Med, 48, pp. 1699-1707
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 249-258.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article, Review,
Impact factor: 1.724, 5-year impact factor Impact factor a 5 anni: 1.952
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-77958610812&partnerID=40&md5=2b443643bb9141a61702f320d72b25a7
Keywords Parole chiave: Extracellular Matrix, Matrix Metalloproteinases, Molecular Imaging, 10 Tetraazacyclododecane 1, 10 Tetraacetic Acid, 2 (n Benzyl 4 Methoxybenzenesulfonamido) N Hydroxy 3 Methylbutanamide, Cgs 27023 A, Copper 64, Cyclin D1, Cytokine, Fibroblast Growth Factor, Fibronectin, Gadolinium, Gelatinase A, Iodine 124, Messenger Rna, Nanoparticle, Scatter Factor, Somatomedin, Unclassified Drug, Urokinase, Urokinase Receptor, Arthritis, Breast Adenocarcinoma, Cancer Cell, Cell Infiltration, Cell Interaction, Enzyme Synthesis, Extracellular Fluid, Glycolysis, Host Cell, Human, Hypoxia, Immunocompetent Cell, Kaposi Sarcoma, Molecular Probe, Nonhuman, Nuclear Magnetic Resonance Imaging, Nuclear Magnetic Resonance Spectroscopy, Phenotype, Review, Tumor Microenvironment, Animals, Hydrogen-Ion Concentration, Extracellular Matrix Physiology, Matrix Metalloproteinases Metabolism, Tumor Microenvironment Physiology, Diagnostic Imaging, Drug Delivery System, Editorial, Genetic Procedures, Nuclear Medicine, Molecular Probe Techniques, Angiogenesis, Carcinogenesis, Disease Course, Positron Emission Tomography, Treatment Response, Tumor Growth, Neovascularization, Pathologic,
Affiliations Affiliazioni:
*** IBB - CNR ***
Department of Biomorphological and Functional Sciences, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy
Institute of Biostructures and Bioimages, National Research Council, Naples, Italy
Centre of Excellence of Neurodegenerative Diseases, Institute of Pharmacological Sciences, University of Milan, Milan, Italy.
Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institute of Health (NIH), Bethesda, MD, United States
References Riferimenti:
Bhowmick, N.A., Moses, H.L., Tumor-stroma interactions (2005) Curr Opin Genet Dev, 15, pp. 97-10
Mueller, M.M., Fusenig, N.E., Friends or foes - Bipolar effects of the tumour stroma in cancer (2004) Nat Rev Cancer, 4, pp. 839-849
Joyce, J.A., Pollard, J.W., Microenvironmental regulation of metastasis (2009) Nat Rev Cancer, 9, pp. 239-252
Pietras, K., Ostman, A., Hallmarks of cancer: Interactions with the tumor stroma (2010) Exp Cell Res, , doi:10.10l6/j.yexcr.2010.02.045
Cretu, A., Brooks, P.C., Impact of the non-cellular tumor microenvironment on metastasis: Potential therapeutic and imaging opportunities (2007) J Cell Physiol, 213, pp. 391-402
Dang, C.V., Kim, J.W., Gao, P., Yustein, J., The interplay between MYC and HIF in cancer (2008) Nat Rev Cancer, 8, pp. 51-56
Gatenby, R.A., Gillies, R.J., A microenvironmental model of carcinogenesis (2008) Nat Rev Cancer, 8, pp. 56-61
Denko, N.C., Hypoxia, HIF1 and glucose metabolism in the solid tumour (2008) Nat Rev Cancer, 8, pp. 705-713
Mason, R.B., Zhao, D., Pecheco-Torres, J., Cui, W., Kodibagkar, V.D., Gulaka, P.K., Multimodality imaging of hypoxia in preclinical settings (2010) Q J Nucl Med Mol Imaging, 54, pp. 259-280
Vander Heiden, M.G., Cantley, L.C., Thompson, C.B., Understanding the Warburg effect: The metabolic requirements of cell proliferation (2009) Science, 324, pp. 1029-1033
Gillies, R.J., Robey, I., Gatenby, R.A., Causes and consequences of increased glucose metabolism of cancers (2008) J Nucl Med, 49 (SUPPL. 2), pp. 24S-42S
Plathow, C., Weber, W.A., Tumor cell metabolism imaging (2008) J Nucl Med, 49 (SUPPL. 2), pp. 43S-63S
Meads, M.B., Gatenby, R.A., Dalton, W.S., Environment-mediated drug resistance: A major contributor to minimal residual disease (2009) Nat Rev Cancer, 9, pp. 665-674
Stubbs, M., McSheehy, P.M., Griffiths, J.R., Causes and consequences of acidic pH in tumors: A magnetic resonance study (1999) Adv Enzyme Regul, 39, pp. 13-30
Raghunand, N., Gillies, R.J., pH and chemotherapy (2001) Novartis Found Symp, 240, pp. 199-211. , discussion 65-8
Rajendran, J.G., Krohn, K.A., Imaging hypoxia and angiogenesis in tumors (2005) Radiol Clin North Am, 43, pp. 169-187
Griffiths, J.R., Stevens, A.N., Iles, R.A., Gordon, R.E., Shaw, D., 31P-NMR investigation of solid tumours in the living rat (1981) Biosci Rep, 1, pp. 319-325
Evanochko, W.T., Ng, T.C., Lilly, M.B., Lawson, A.J., Corbett, T.H., Durant, J.R., In vivo 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia (1983) Proc Natl Acad Sci U S A, 80, pp. 334-338
Griffiths, J.R., Are cancer cells acidic? (1991) Br J Cancer, 64, pp. 425-427
Gillies, R.J., Liu, Z., Bhujwalla, Z., 31P-MRS measurements of extra-cellular pH of tumors using 3-aminopropylphosphonate (1994) Am J Physiol, 267, pp. C195-203
Gil, S., Zaderenzo, P., Cruz, F., Cerdan, S., Ballesteros, P., Imidazol-1-ylalkanoic acids as extrinsic 1H NMR probes for the determination of intracellular pH, extracellular pH and cell volume (1994) Bioorg Med Chem, 2, pp. 305-314
Zhou, J., Payen, J.F., Wilson, D.A., Traystman, R.J., Van Zijl, P.C., Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI (2003) Nat Med, 9, pp. 1085-1090
Aime, S., Barge, A., Delli Castelli, D., Fedeli, F., Mortillaro, A., Nielsen, F.U., Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications (2002) Magn Reson Med, 47, pp. 639-648
Garcia-Martin, M.L., Martinez, G.V., Raghunand, N., Sherry, A.D., Zhang, S., Gillies, R.J., High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity (2006) Magn Reson Med, 55, pp. 309-315
Gallagher, F.A., Kettunen, M.I., Day, S.E., Hu, D.E., Ardenkjaer-Larsen, J.H., Zandt, R., Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate (2008) Nature, 453, pp. 940-943
Andreev, O.A., Dupuy, A.D., Segala, M., Sandugu, S., Serra, D.A., Chichester, C.O., Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo (2007) Proc Natl Acad Sci U S A, 104, pp. 7893-7898
Urano, Y., Asanuma, D., Hama, Y., Koyama, Y., Barrett, T., Kamiya, M., Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes (2009) Nat Med, 15, pp. 104-109
Vavere, A.L., Biddlecombe, G.B., Spees, W.M., Garbow, J.R., Wijesinghe, D., Andreev, O.A., A novel technology for the imaging of acidic prostate tumors by positron emission tomography (2009) Cancer Res, 69, pp. 4510-4516
Egeblad, M., Werb, Z., New functions for the matrix metalloproteinases in cancer progression (2002) Nat Rev Cancer, 2, pp. 161-174
Smith, H.W., Marshall, C.J., Regulation of cell signalling by uPAR (2010) Nat Rev Mol Cell Biol, 11, pp. 23-36
Bremer, C., Tung, C.H., Weissleder, R., In vivo molecular target assessment of matrix metalloproteinase inhibition (2001) Nat Med, 7, pp. 743-748
Scherer, R.L., VanSaun, M.N., McIntyre, J.O., Matrisian, L.M., Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon (2008) Mol Imaging, 7, pp. 118-131
Jiang, T., Olson, E.S., Nguyen, Q.T., Roy, M., Jennings, P.A., Tsien, R.Y., Tumor imaging by means of proteolytic activation of cell-penetrating peptides (2004) Proc Natl Acad Sci U S A, 101, pp. 17867-17872
Olson, E.S., Aguilera, T.A., Jiang, T., Ellies, L.G., Nguyen, Q.T., Wong, E.H., In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer (2009) Integr Biol, 1, pp. 382-393. , Camb
Breyholz, H.J., Wagner, S., Levkau, B., Schober, O., Schafers, M., Kopka, K., A 18F-radiolabeled analogue of CGS 27023A as a potential agent for assessment of matrix-metalloproteinase activity in vivo (2007) Q J Nucl Med Mol Imaging, 51, pp. 24-32
Zheng, Q.H., Fei, X., Liu, X., Wang, J.Q., Stone, K.L., Martinez, T.D., Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4′-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4′-[11C]methoxyphenyl)sulfonyl]benzylamino]- 3-methylbut anamide (2004) Nucl Med Biol, 31, pp. 77-85
Kopka, K., Breyholz, H.J., Wagner, S., Uw, M.P., Riemann, B., Schroer, S., Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo (2004) Nucl Med Biol, 31, pp. 257-267
Schafers, M., Riemann, B., Kopka, K., Breyholz, H.J., Wagner, S., Schafers, K.P., Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo (2004) Circulation, 109, pp. 2554-2559
Wagner, S., Breyholz, H.J., Holtke, C., Faust, A., Schober, O., Schafers, M., A new 18F-labelled derivative of the MMP inhibitor CGS 27023A for PET: Radiosynthesis and initial small-animal PET studies (2009) Appl Radiat Isot, 67, pp. 606-610
Kulasegaram, R., Giersing, B., Page, C.J., Blower, P.J., Williamson, R.A., Peters, B.S., In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection (2001) Eur J Nucl Med, 28, pp. 756-761
Lepage, M., Dow, W.C., Melchior, M., You, Y., Fingleton, B., Quarles, C.C., Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch (2007) Mol Imaging, 6, pp. 393-403
Lebel, R., Jastrzebska, B., Therriault, H., Cournoyer, M.M., McIntyre, J.O., Escher, E., Novel solubility-switchable MRI agent allows the noninvasive detection of matrix metalloproteinase-2 activity in vivo in a mouse model (2008) Magn Reson Med, 60, pp. 1056-1065
Olson, E.S., Jiang, T., Aguilera, T.A., Nguyen, Q.T., Ellies, L.G., Scadeng, M., Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases (2010) Proc Natl Acad Sci U S A, 107, pp. 4311-4316
D'Alessio, S., Blasi, F., The urokinase receptor as an entertainer of signal transduction (2009) Front Biosci, 14, pp. 4575-4587
Dass, K., Ahmad, A., Azmi, A.S., Sarkar, S.H., Sarkar, F.H., Evolving role of uPA/uPAR system in human cancers (2008) Cancer Treat Rev, 34, pp. 122-136
Del Vecchio, S., Stoppelli, M.P., Carriero, M.V., Fonti, R., Massa, O., Li, P.Y., Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels (1993) Cancer Res, 53, pp. 3198-3206
Zannetti, A., Del Vecchio, S., Carriero, M.V., Fonti, R., Franco, P., Botti, G., Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma (2000) Cancer Res, 60, pp. 1546-1551
Shariat, S.F., Roehrborn, C.G., McConnell, J.D., Park, S., Alam, N., Wheeler, T.M., Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis (2007) J Clin Oncol, 25, pp. 349-355
Stephens, R.W., Nielsen, H.J., Christensen, I.J., Thorlacius-Ussing, O., Sorensen, S., Dano, K., Plasma urokinase receptor levels in patients with colorectal cancer: Relationship to prognosis (1999) J Natl Cancer Inst, 91, pp. 869-874
Li, Z.B., Niu, G., Wang, H., He, L., Yang, L., Ploug, M., Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET (2008) Clin Cancer Res, 14, pp. 4758-4766
Yang, L., Peng, X.H., Wang, Y.A., Wang, X., Cao, Z., Ni, C., Receptor-targeted nanoparticles for in vivo imaging of breast cancer (2009) Clin Cancer Res, 15, pp. 4722-4732
Santimaria, M., Moscatelli, G., Viale, G.L., Giovannoni, L., Neri, G., Viti, F., Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer (2003) Clin Cancer Res, 9, pp. 571-579
Berndorff, D., Borkowski, S., Moosmayer, D., Viti, F., Muller-Tiemann, B., Sieger, S., Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments (2006) J Nucl Med, 47, pp. 1707-1716
Tijink, B.M., Perk, L.R., Budde, M., Stigter-van Walsum, M., Visser, G.W., Kloet, R.W., (124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy (2009) Eur J Nucl Med Mol Imaging, 36, pp. 1235-1244
Rossin, R., Berndorff, D., Friebe, M., Dinkelborg, L.M., Welch, M.J., Small-animal PET of tumor angiogenesis using a (76)Br-labeled human recombinant antibody fragment to the ED-B domain of fibronectin (2007) J Nucl Med, 48, pp. 1172-1179
Orend, G., Chiquet-Ehrismann, R., Tenascin-C induced signaling in cancer (2006) Cancer Lett, 244, pp. 143-163
Herold-Mende, C., Mueller, M.M., Bonsanto, M.M., Schmitt, H.P., Kunze, S., Steiner, H.H., Clinical impact and functional aspects of tenascin-C expression during glioma progression (2002) Int J Cancer, 98, pp. 362-369
Riva, P., Franceschi, G., Riva, N., Casi, M., Santimaria, M., Adamo, M., Role of nuclear medicine in the treatment of malignant gliomas: The locoregional radioimmunotherapy approach (2000) Eur J Nucl Med, 27, pp. 601-609
Akabani, G., Reardon, D.A., Coleman, R.E., Wong, T.Z., Metzler, S.D., Bowsher, J.E., Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: A phase II study (2005) J Nucl Med, 46, pp. 1042-1051
Zalutsky, M.R., Reardon, D.A., Akabani, G., Coleman, R.E., Friedman, A.H., Friedman, H.S., Clinical experience with alpha-particle emitting 211At: Treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6 (2008) J Nucl Med, 49, pp. 30-38
Paganelli, G., Grana, C., Chinol, M., Cremonesi, M., De Cicco, C., De Braud, F., Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin (1999) Eur J Nucl Med, 26, pp. 348-357
Hicke, B.J., Stephens, A.W., Gould, T., Chang, Y.F., Lynott, C.K., Heil, J., Tumor targeting by an aptamer (2006) J Nucl Med, 47, pp. 668-678
Zhu, L., Niu, G., Fang, X., Chen, X., Preclinical molercular imaging of tumor angiogenesis (2010) Q J Nucl Med Mol Imaging, 54, pp. 291-308
Hay, R.V., Cao, B., Skinner, R.S., Su, Y., Zhao, P., Gustafson, M.F., Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek) (2005) Clin Cancer Res, 11, pp. 7064s-9s
Perk, L.R., Stigter-van Walsum, M., Visser, G.W., Kloet, R.W., Vosjan, M.J., Leemans, C.R., Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30 (2008) Eur J Nucl Med Mol Imaging, 35, pp. 1857-1867
Shaharabany, M., Abramovitch, R., Kushnir, T., Tsarfaty, G., Ravid-Megido, M., Horev, J., In vivo molecular imaging of met tyrosine kinase growth factor receptor activity in normal organs and breast tumors (2001) Cancer Res, 61, pp. 4873-4878
Cornelissen, B., McLarty, K., Kersemans, V., Reilly, R.M., The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of (111)In-IGF-1(E3R) in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab (Herceptin) (2008) Nucl Med Biol, 35, pp. 645-653
Tian, X., Aruva, M.R., Zhang, K., Shanthly, N., Cardi, C.A., Thakur, M.L., PET imaging of CCND1 mRNA in human MCF7 estrogen receptor positive breast cancer xenografts with oncogene-specific [64Cu]chelator-peptide nucleic acid-IGF1 analog radiohybridization probes (2007) J Nucl Med, 48, pp. 1699-1707
Koizumi, K., Hojo, S., Akashi, T., Yasumoto, K., Saiki, I., Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response (2007) Cancer Sci, 98, pp. 1652-1658
Jacobson, O., Weiss, I.D., Szajek, L., Farber, J.M., Kiesewetter, D.O., 64Cu-AMD3100 - A novel imaging agent for targeting chemokine receptor CXCR4 (2009) Bioorg Med Chem, 17, pp. 1486-1493
Nimmagadda, S., Pullambhatla, M., Pomper, M.G., Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT (2009) J Nucl Med, 50, pp. 1124-1130
Bhowmick, N. A., Moses, H. L., Tumor-stroma interactions (2005) Curr Opin Genet Dev, 15, pp. 97-10
Mueller, M. M., Fusenig, N. E., Friends or foes - Bipolar effects of the tumour stroma in cancer (2004) Nat Rev Cancer, 4, pp. 839-849
Joyce, J. A., Pollard, J. W., Microenvironmental regulation of metastasis (2009) Nat Rev Cancer, 9, pp. 239-252
Dang, C. V., Kim, J. W., Gao, P., Yustein, J., The interplay between MYC and HIF in cancer (2008) Nat Rev Cancer, 8, pp. 51-56
Gatenby, R. A., Gillies, R. J., A microenvironmental model of carcinogenesis (2008) Nat Rev Cancer, 8, pp. 56-61
Denko, N. C., Hypoxia, HIF1 and glucose metabolism in the solid tumour (2008) Nat Rev Cancer, 8, pp. 705-713
Mason, R. B., Zhao, D., Pecheco-Torres, J., Cui, W., Kodibagkar, V. D., Gulaka, P. K., Multimodality imaging of hypoxia in preclinical settings (2010) Q J Nucl Med Mol Imaging, 54, pp. 259-280
Vander Heiden, M. G., Cantley, L. C., Thompson, C. B., Understanding the Warburg effect: The metabolic requirements of cell proliferation (2009) Science, 324, pp. 1029-1033
Gillies, R. J., Robey, I., Gatenby, R. A., Causes and consequences of increased glucose metabolism of cancers (2008) J Nucl Med, 49 (SUPPL. 2), pp. 24S-42S
Meads, M. B., Gatenby, R. A., Dalton, W. S., Environment-mediated drug resistance: A major contributor to minimal residual disease (2009) Nat Rev Cancer, 9, pp. 665-674
Rajendran, J. G., Krohn, K. A., Imaging hypoxia and angiogenesis in tumors (2005) Radiol Clin North Am, 43, pp. 169-187
Griffiths, J. R., Stevens, A. N., Iles, R. A., Gordon, R. E., Shaw, D., 31P-NMR investigation of solid tumours in the living rat (1981) Biosci Rep, 1, pp. 319-325
Evanochko, W. T., Ng, T. C., Lilly, M. B., Lawson, A. J., Corbett, T. H., Durant, J. R., In vivo 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia (1983) Proc Natl Acad Sci U S A, 80, pp. 334-338
Griffiths, J. R., Are cancer cells acidic? (1991) Br J Cancer, 64, pp. 425-427
Gillies, R. J., Liu, Z., Bhujwalla, Z., 31P-MRS measurements of extra-cellular pH of tumors using 3-aminopropylphosphonate (1994) Am J Physiol, 267, pp. C195-203
Zhou, J., Payen, J. F., Wilson, D. A., Traystman, R. J., Van Zijl, P. C., Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI (2003) Nat Med, 9, pp. 1085-1090
Garcia-Martin, M. L., Martinez, G. V., Raghunand, N., Sherry, A. D., Zhang, S., Gillies, R. J., High resolution pH (e) imaging of rat glioma using pH-dependent relaxivity (2006) Magn Reson Med, 55, pp. 309-315
Gallagher, F. A., Kettunen, M. I., Day, S. E., Hu, D. E., Ardenkjaer-Larsen, J. H., Zandt, R., Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate (2008) Nature, 453, pp. 940-943
Andreev, O. A., Dupuy, A. D., Segala, M., Sandugu, S., Serra, D. A., Chichester, C. O., Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo (2007) Proc Natl Acad Sci U S A, 104, pp. 7893-7898
Vavere, A. L., Biddlecombe, G. B., Spees, W. M., Garbow, J. R., Wijesinghe, D., Andreev, O. A., A novel technology for the imaging of acidic prostate tumors by positron emission tomography (2009) Cancer Res, 69, pp. 4510-4516
Smith, H. W., Marshall, C. J., Regulation of cell signalling by uPAR (2010) Nat Rev Mol Cell Biol, 11, pp. 23-36
Scherer, R. L., VanSaun, M. N., McIntyre, J. O., Matrisian, L. M., Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon (2008) Mol Imaging, 7, pp. 118-131
Olson, E. S., Aguilera, T. A., Jiang, T., Ellies, L. G., Nguyen, Q. T., Wong, E. H., In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer (2009) Integr Biol, 1, pp. 382-393. , Camb
Breyholz, H. J., Wagner, S., Levkau, B., Schober, O., Schafers, M., Kopka, K., A 18F-radiolabeled analogue of CGS 27023A as a potential agent for assessment of matrix-metalloproteinase activity in vivo (2007) Q J Nucl Med Mol Imaging, 51, pp. 24-32
Zheng, Q. H., Fei, X., Liu, X., Wang, J. Q., Stone, K. L., Martinez, T. D., Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S) -2- (4 - [11C] methoxybiphenyl-4-sulfonylamino) -3-methylbutyric acid and N-hydroxy- (R) -2- [[(4 - [11C] methoxyphenyl) sulfonyl] benzylamino] - 3-methylbut anamide (2004) Nucl Med Biol, 31, pp. 77-85
Lepage, M., Dow, W. C., Melchior, M., You, Y., Fingleton, B., Quarles, C. C., Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch (2007) Mol Imaging, 6, pp. 393-403
Olson, E. S., Jiang, T., Aguilera, T. A., Nguyen, Q. T., Ellies, L. G., Scadeng, M., Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases (2010) Proc Natl Acad Sci U S A, 107, pp. 4311-4316
Shariat, S. F., Roehrborn, C. G., McConnell, J. D., Park, S., Alam, N., Wheeler, T. M., Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis (2007) J Clin Oncol, 25, pp. 349-355
Stephens, R. W., Nielsen, H. J., Christensen, I. J., Thorlacius-Ussing, O., Sorensen, S., Dano, K., Plasma urokinase receptor levels in patients with colorectal cancer: Relationship to prognosis (1999) J Natl Cancer Inst, 91, pp. 869-874
Li, Z. B., Niu, G., Wang, H., He, L., Yang, L., Ploug, M., Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET (2008) Clin Cancer Res, 14, pp. 4758-4766
Yang, L., Peng, X. H., Wang, Y. A., Wang, X., Cao, Z., Ni, C., Receptor-targeted nanoparticles for in vivo imaging of breast cancer (2009) Clin Cancer Res, 15, pp. 4722-4732
Tijink, B. M., Perk, L. R., Budde, M., Stigter-van Walsum, M., Visser, G. W., Kloet, R. W., (124) I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131) I-L19-SIP radioimmunotherapy (2009) Eur J Nucl Med Mol Imaging, 36, pp. 1235-1244
Zalutsky, M. R., Reardon, D. A., Akabani, G., Coleman, R. E., Friedman, A. H., Friedman, H. S., Clinical experience with alpha-particle emitting 211At: Treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6 (2008) J Nucl Med, 49, pp. 30-38
Hicke, B. J., Stephens, A. W., Gould, T., Chang, Y. F., Lynott, C. K., Heil, J., Tumor targeting by an aptamer (2006) J Nucl Med, 47, pp. 668-678
Hay, R. V., Cao, B., Skinner, R. S., Su, Y., Zhao, P., Gustafson, M. F., Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek) (2005) Clin Cancer Res, 11, pp. 7064s-9s
Perk, L. R., Stigter-van Walsum, M., Visser, G. W., Kloet, R. W., Vosjan, M. J., Leemans, C. R., Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30 (2008) Eur J Nucl Med Mol Imaging, 35, pp. 1857-1867
Tian, X., Aruva, M. R., Zhang, K., Shanthly, N., Cardi, C. A., Thakur, M. L., PET imaging of CCND1 mRNA in human MCF7 estrogen receptor positive breast cancer xenografts with oncogene-specific [64Cu] chelator-peptide nucleic acid-IGF1 analog radiohybridization probes (2007) J Nucl Med, 48, pp. 1699-1707
Molecular imaging of tumor microenvironment: Challenges and perspectives
Tumor microenvironment consists of a number of components including host resident stromal cells, infiltrating immune cells and extracellular matrix. The architecture surrounding tumor cells is not static but is subjected to a continuous remodeling in response to the dynamic interplay between tumor and stromal cells and to the production of extracellular proteases. In addition all these microenvironmental components along with cancer cells are exposed to abnormal physiologic conditions such as hypoxia and acidic extracellular pH that may induce both adaptive and constitutive changes in cancer and stromal cells. In this review, we will primarily focus on the possibility to visualize in vivo tumor microenvironment components and conditions as well as interactions with cancer cells. The major goal is to highlight the difficulties and the opportunities of this approach and how each imaging technology helps to overcome specific challenge.
Tumor microenvironment consists of a number of components including host resident stromal cells, infiltrating immune cells and extracellular matrix. The architecture surrounding tumor cells is not static but is subjected to a continuous remodeling in response to the dynamic interplay between tumor and stromal cells and to the production of extracellular proteases. In addition all these microenvironmental components along with cancer cells are exposed to abnormal physiologic conditions such as hypoxia and acidic extracellular pH that may induce both adaptive and constitutive changes in cancer and stromal cells. In this review, we will primarily focus on the possibility to visualize in vivo tumor microenvironment components and conditions as well as interactions with cancer cells. The major goal is to highlight the difficulties and the opportunities of this approach and how each imaging technology helps to overcome specific challenge.
Molecular imaging of tumor microenvironment: Challenges and perspectives
_Valeria_Menchise_423.jpg){kind=small}
Molecular imaging of tumor microenvironment: Challenges and perspectives
Ngoc B, Vu Hoa T, N , Palumbo R, Rinaldo P, Fagoonee S, Phuc V
* Stem cell-derived exosomes for wound healing: current status and promising directions (33 visite)
Minerva Med (ISSN: 0026-4806linking), 2021 Jun; 112(3): 384-400.
Impact Factor: 3.031
Dettagli Esporta in BibTeX Esporta in EndNote
Hill BS, Sarnella A, D'Avino G, Zannetti A
* Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer (187 visite) (PDF 38 visite)
Semin Cancer Biol (ISSN: 1044-579xlinking), 2020 Feb; 60: 202-213.
Impact Factor: 11.09
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore B, Caprio MG, Hill BS, Sarnella A, Roviello GN, Zannetti A
* Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer (193 visite) (PDF 82 visite)
Cancers (ISSN: 2072-6694linking), 2019 Oct 22; 11(10): N/D-N/D.
Impact Factor: 6.162
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Stanzione A, Guarino S, Romeo V, Ugga L, Romano F, Storto G, Maurea S, Brunetti A
* Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging (123 visite)
World J Gastroentero (ISSN: 1007-9327linking, 2219-2840), 2019 Sep 21; 25 (35 ): 5233-5256.
Impact Factor: 2.24
Dettagli Esporta in BibTeX Esporta in EndNote
Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH, Bottlaender M, Brooks D, Carroll MA, Chalon S, Gee A, Gerhard A, Halldin C, Herholz K, Herth MM, Hinz R, Knudsen GM, Kuhnast B, López-picón F, Moresco RM, Pappata S, Rinne JO, Rodriguez-vieitez E, Santiago-ribeiro MJ, Turkheimer FE, Van Laere K, Varrone A, Vercouillie J, Winkeler A
* A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies (189 visite)
Alzheimers Dement (ISSN: 1552-5260linking), 2019 Jun 20; N/D: N/D-N/D.
Impact Factor: 14.43
Dettagli Esporta in BibTeX Esporta in EndNote
Mcnitt DH, Choi SJ, Allen JL, Hames RA, Weed SA, Van De Water L, Berisio R, Lukomski S
* Adaptation of the group A Streptococcus adhesin Scl1 to bind fibronectin type III repeats within wound-associated extracellular matrix: implications for cancer therapy (178 visite)
Mol Microbiol (ISSN: 0950-382xlinking), 2019 May 30; N/D: N/D-N/D.
Impact Factor: 3.816
Dettagli Esporta in BibTeX Esporta in EndNote
Perani D, Iaccarino L, Jacobs AH, Lammertsma AA, Nordberg A, Windhorst AD, Gerhard A, Winkeler A, Jacobs AH, Gee A, Kuhnast B, Halldin C, Perani D, Brooks D, Rodriguez-vieitez E, Turkheimer FE, López-picón F, Knudsen GM, Vercouillie J, Rinne JO, Herholz K, Van Laere K, Santiago-ribeiro MJ, Herth MM, Carroll MA, Bottlaender M, Hansson O, Edison P, Hinz R, Boellaard R, Moresco RM, Pappata S
* Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies (233 visite)
Alzheimers Dement (ISSN: 2352-8729print), 2019 Apr 16; 11: 327-332.
Impact Factor: 14.423
Dettagli Esporta in BibTeX Esporta in EndNote
Baroni S, Ruggiero MR, Aime S, Geninatti Crich S
* Exploring the tumour extracellular matrix by in vivo Fast Field Cycling relaxometry after the administration of a Gadolinium-based MRI contrast agent (220 visite)
Magn Reson Chem (ISSN: 0749-1581linking), 2019 Jan 24; N/D: N/D-N/D.
Impact Factor: 1.601
Dettagli Esporta in BibTeX Esporta in EndNote
Squeglia F, Ruggiero A, Berisio R
* Collagen degradation in tuberculosis pathogenesis: the biochemical consequences of hosting an undesired guest (355 visite)
Biochem J (ISSN: 1470-8728electronic, 0264-6021linking, 0264-6021print), 2018 Oct 11; 475(19): 3123-3140.
Impact Factor: 4.897
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Pappata S, Zampella E, Assante R
* Advances in SPECT Methodology (237 visite)
Int Rev Neurobiol (ISSN: 0074-77429780128154182, 2162-5514electronic), 2018 Sep; 141: 77-96.
Impact Factor: 3.36
Dettagli Esporta in BibTeX Esporta in EndNote
Camorani S, Hill BS, Fontanella R, Greco A, Gramanzini M, Auletta L, Gargiulo S, Albanese S, Lucarelli E, Cerchia L, Zannetti A
* Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRbeta Aptamer (629 visite) (PDF 200 visite)
Theranostics (ISSN: 1838-7640, 1838-7640electronic), 2017 Aug 22; 7(14): 3595-3607.
Impact Factor: 8.537
Dettagli Esporta in BibTeX Esporta in EndNote
Longo DL, Stefania R, Aime S, Oraevsky A
* Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications (244 visite)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2017 Aug 7; 18(8): N/D-N/D.
Impact Factor: 3.687
Dettagli Esporta in BibTeX Esporta in EndNote
Gargiulo S, Coda AR, Panico M, Gramanzini M, Moresco RM, Chalon S, Pappata S
* Molecular imaging of neuroinflammation in preclinical rodent models using positron emission tomography (287 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1827-1936), 2017 Mar; 61(1): 60-75.
Impact Factor: 2.368
Dettagli Esporta in BibTeX Esporta in EndNote
Auletta L, Gramanzini M, Gargiulo S, Albanese S, Salvatore M, Greco A
* Advances in multimodal molecular imaging (297 visite)
Q J Nucl Med Mol Imaging, 2017; N/D: N/D-N/D.
Impact Factor: 2.413
Dettagli Esporta in BibTeX Esporta in EndNote
Morbelli S, Arbizu J, Booij J, Chen M-K, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H
* Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 3, (353-357), 10. 1007/s00259-016-3589-9) (175 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2017; 44(3): 559-560.
Impact Factor: 7.704
Dettagli Esporta in BibTeX Esporta in EndNote
Longo DL, Moustaghfir FZ, Zerbo A, Consolino L, Anemone A, Bracesco M, Aime S
* EXCI-CEST: Exploiting pharmaceutical excipients as MRI-CEST contrast agents for tumor imaging (299 visite)
Int J Pharm (ISSN: 0378-5173, 1873-3476), 2017; 525(1): 275-281.
Impact Factor: 3.862
Dettagli Esporta in BibTeX Esporta in EndNote
Gargiulo S, Gramanzini M, Mancini M
* Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models (332 visite) (PDF 181 visite)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2016 Sep 9; 17(9): N/D-N/D.
Impact Factor: 3.226
Dettagli Esporta in BibTeX Esporta in EndNote
Zinnhardt B, Viel T, Wachsmuth L, Vrachimis A, Wagner S, Breyholz HJ, Faust A, Hermann S, Kopka K, Faber C, Dolle F, Pappata S, Planas AM, Tavitian B, Schafers M, Sorokin LM, Kuhlmann MT, Jacobs AH
* Multimodal imaging reveals temporal and spatial microglia and matrix metalloproteinase activity after experimental stroke (291 visite)
J Cerebr Blood F Met (ISSN: 0271-678x), 2015 Nov; 35(11): 1711-1721.
Impact Factor: 4.929
Dettagli Esporta in BibTeX Esporta in EndNote
Longo DL, Arena F, Consolino L, Minazzi P, Geninatti-crich S, Giovenzana GB, Aime S
* Gd-AAZTA-MADEC, an improved blood pool agent for DCE-MRI studies on mice on 1 T scanners (349 visite)
Biomaterials (ISSN: 0142-9612, 1878-5905electronic, 0142-9612linking), 2015 Oct 16; 75: 47-57.
Impact Factor: 8.387
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Gallicchio R, Maddalena F, Pellegrino T, Petretta M, Fiumara G, Cuocolo A
* Estimation of coronary flow reserve by sestamibi imaging in patients with mild hypertension and normal coronary arteries (276 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1827-1936), 2014 Mar 14; 59(3): 336-341.
Impact Factor: 2.033
Dettagli Esporta in BibTeX Esporta in EndNote
Iommelli F, De Rosa V, Fonti R, Del Vecchio S
* Molecular Imaging For Detection Of Sensitivity And Resistance To Egfr Tyrosine Kinase Inhibitors In Non-Small Cell Lung Cancer (259 visite)
Clin Transl Imaging (ISSN: 2281-5872print, 2281-7565online), 2014 Feb 20; 2(1): 43-53.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Petretta A, Pellegrino T, Nappi C, Cantoni V, Cuocolo A
* Nuclear Cardiology in Heart Failure (331 visite)
Curr Cardiovasc Imaging Rep (ISSN: 1941-9066), 2014 Jan; 7(3): 1-7.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Giuffrida ML, Rizzarelli E, Tomaselli GA, Satriano C, Trusso Sfrazzetto G
* A novel fully water-soluble Cu(i) probe for fluorescence live cell imaging (340 visite)
Chem Commun (ISSN: 1359-7345, 1364-548x, 1364-548xelectronic), 2014; 50(69): 9835-9838.
Impact Factor: 6.834
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Greco A, Salvatore G, Liuzzi R, Di Maro G, Vergara E, Chiappetta G, Pasquinelli R, Brunetti A, Salvatore M
* Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice (430 visite)
Bmc Med Imaging (ISSN: 1471-2342, 1471-2342electronic), 2013 Sep 12; 13(1): 31-31.
Impact Factor: 0.983
Dettagli Esporta in BibTeX Esporta in EndNote
Calce E, Monfregola L, De Luca S
* Synthetic Strategy to Prepare DOTA-Based Bifunctional Chelating Agent Ready to Bind Biomolecular Probes (393 visite)
Int J Pept Res Ther (ISSN: 1573-3149, 0929-5666), 2013 Sep; 19(3): 199-202.
Impact Factor: 0.825
Dettagli Esporta in BibTeX Esporta in EndNote
Booij J, Arbizu J, Darcourt J, Hesse S, Nobili F, Payoux P, Pappata S, Tatsch K, Walker Z, Pagani M
* Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine (477 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Jul; 40(7): 1122-1125.
Impact Factor: 5.217
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Fiumara G, Pellegrino T, Zampella E, Assante R, Mainenti PP, Cuocolo A
* MIBG molecular imaging for evaluating response to chemotherapy in patients with malignant pheochromocytoma: preliminary results (235 visite)
Cancer Imaging (ISSN: 1470-7330, 1470-7330electronic, 1470-7330linking), 2013 Apr 15; 13: 155-161.
Impact Factor: 1.286
Dettagli Esporta in BibTeX Esporta in EndNote
Catanzaro V, Gringeri CV, Menchise V, Padovan S, Boffa C, Dastru W, Chaabane L, Digilio G, Aime S
* A R2p/R1p ratiometric procedure to assess matrix metalloproteinase-2 activity by magnetic resonance imaging (341 visite)
Angew Chem Int Ed (ISSN: 1433-7851, 1521-3773electronic), 2013 Apr 2; 52(14): 3926-3930.
Impact Factor: 11.336
Dettagli Esporta in BibTeX Esporta in EndNote
Greco A, Fiumara G, Gargiulo S, Gramanzini M, Brunetti A, Cuocolo A
* High-resolution positron emission tomography/computed tomography imaging of the mouse heart (423 visite)
Exp Physiol Experimental Physiology (ISSN: 1469-445x, 0958-0670), 2013 Mar; 98(3): 645-651.
Impact Factor: 2.871
Dettagli Esporta in BibTeX Esporta in EndNote
D'Agata R, Spoto G
* Surface plasmon resonance imaging for nucleic acid detection (318 visite)
Anal Bioanal Chem (ISSN: 1618-2642), 2013 Jan; 405(2-3): 573-584.
Impact Factor: 3.578
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Cuocolo A
In search of a marker of vulnerable carotid plaque: is the key in the heart? (261 visite)
Atherosclerosis (ISSN: 1879-1484, 0021-9150), 2012 Jul; 223(1): 95-97.
Impact Factor: 3.706
Dettagli Esporta in BibTeX Esporta in EndNote
Jacobs AH, Tavitian B, TheInmindG, Pappata S, Quarantelli M
* Noninvasive molecular imaging of neuroinflammation (314 visite) (PDF 189 visite)
J Cereb Blood Flow Metab (ISSN: 0271-678x, 1559-7016electronic), 2012 Jul; 32(7): 1393-1415.
Impact Factor: 5.398
Dettagli Esporta in BibTeX Esporta in EndNote
Gringeri CV, Menchise V, Rizzitelli S, Cittadino E, Catanzaro V, Dati G, Chaabane L, Digilio G, Aime S
* Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases (440 visite)
Contrast Media Mol Imaging (ISSN: 1555-4309, 1555-4309linking), 2012 Mar; 7(2): 175-184.
Impact Factor: 2.872
Dettagli Esporta in BibTeX Esporta in EndNote
Gargiulo S, Greco A, Gramanzini M, Esposito S, Affuso A, Brunetti A, Vesce G
* Mice Anesthesia, Analgesia, and Care, Part I: Anesthetic Considerations in Preclinical Research (295 visite)
Ilar J (ISSN: 1084-2020, 1930-6180, 1084-2020linking), 2012; 53(1): 55-69.
Impact Factor: 1.582
Dettagli Esporta in BibTeX Esporta in EndNote
Gargiulo S, Greco A, Gramanzini M, Esposito S, Affuso A, Brunetti A, Vesce G
* Mice anesthesia, analgesia, and care, Part II: anesthetic considerations in preclinical imaging studies (284 visite)
Ilar Jilar Journal / National Research Council Institute Of Laboratory Animal Resources (ISSN: 1930-6180, 1084-2020), 2012; 53(1): 70-81.
Impact Factor: 1.582
Dettagli Esporta in BibTeX Esporta in EndNote
Greco A, Mancini M, Gargiulo S, Gramanzini M, Claudio PP, Brunetti A, Salvatore M
* Ultrasound biomicroscopy in small animal research: Applications in molecular and preclinical imaging (419 visite)
J Biomed Biotechnol (ISSN: 1110-7243, 1110-7251), 2012; 2012: 519238-519238.
Impact Factor: 2.88
Dettagli Esporta in BibTeX Esporta in EndNote
Ocak M, Helbok A, Rangger C, Peitl PK, Nock BA, Morelli G, Eek A, Sosabowskijk, Breeman WA, Reubi JC, Decristoforo C
* Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607 (560 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2011 Sep; 38(8): 1426-1435.
Impact Factor: 4.991
Dettagli Esporta in BibTeX Esporta in EndNote
Gulyas B, Vas A, Toth M, Takano A, Varrone A, Cselenyi Z, Schain M, Mattsson P, Halldin C
* Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine (528 visite)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2011 Jun 1; 56(3): 1111-1121.
Impact Factor: 5.895
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A
Current research in nuclear medicine and molecular imaging in Italy: Highlights of the 10th National Congress of the Italian Association of Nuclear Medicine and Molecular Imaging (400 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2011 Jun; 55(3): 280-300.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Perrone-filardi P, Dellegrottaglie S, Rudd JH, Costanzo P, Marciano C, Vassallo E, Marsico F, Ruggiero D, Petretta MP, Chiariello M, Cuocolo A
* Molecular imaging of atherosclerosis in translational medicine (489 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 May; 38(5): 969-975.
Impact Factor: 4.991
Dettagli Esporta in BibTeX Esporta in EndNote
Ruggiero A, Squeglia F, Marasco D, Marchetti R, Molinaro A, Berisio R
* X-ray structural studies of the entire extracellular region of the serine/threonine kinase PrkC from Staphylococcus aureus (378 visite)
Biochem J (ISSN: 0264-6021, 1470-8728electronic, 0264-6021linking), 2011 Apr 1; 435(1): 33-41.
Impact Factor: 4.897
Dettagli Esporta in BibTeX Esporta in EndNote
Accardo A, Morisco A, Gianolio E, Tesauro D, Mangiapia G, Radulescu A, Brandt A, Morelli G
* Nanoparticles containing octreotide peptides and gadolinium complexes for MRI applications (460 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2011 Feb; 17(2): 154-162.
Impact Factor: 1.799
Dettagli Esporta in BibTeX Esporta in EndNote
Nardelli A, Castaldi E, Ortosecco G, Speranza A, Storto G, Pace L, Salvatore M
* Enhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90 (402 visite)
Applied Radiation And Isotopes (ISSN: 1872-9800, 0969-8043, 0969-8043linking), 2011 Jan; 69(1): 52-55.
Impact Factor: 1.172
Dettagli Esporta in BibTeX Esporta in EndNote
Morisco A, Accardo A, Tesauro D, Palumbo R, Benedetti E, Morelli G
* Peptide-labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells (346 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2011; 96(1): 88-96.
Impact Factor: 2.87
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M
* Detection of colo-rectal liver metastases: Prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1. 5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents (322 visite)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2010 Oct; 35(5): 511-521.
Impact Factor: 1.95
Dettagli Esporta in BibTeX Esporta in EndNote
D'Andrea LD, Romanelli A, Di Stasi R, Pedone C
* Bioinorganic aspects of angiogenesis (362 visite)
Dalton T (ISSN: 1477-9234, 1477-9226, 1477-9234electronic), 2010 Sep 7; 39(33): 7625-7636.
Impact Factor: 3.647
Dettagli Esporta in BibTeX Esporta in EndNote
Varrone A, Halldin C
Molecular imaging of the dopamine transporter (498 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2010 Sep 1; 51(9): 1331-1334.
Impact Factor: 7.022
Dettagli Esporta in BibTeX Esporta in EndNote
Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A
* In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging (429 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jul; 37(7): 1441-1448.
Impact Factor: 5.036
Dettagli Esporta in BibTeX Esporta in EndNote
Gautier B, Goncalves V, Diana D, Di Stasi R, Teillet F, Lenoir C, Huguenot F, Garbay C, Fattorusso R, D'Andrea LD, Vidal M, Inguimbert N
* Biochemical and Structural Analysis of the Binding Determinants of a Vascular Endothelial Growth Factor Receptor Peptidic Antagonist (420 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2010 Jun 10; 53(11): 4428-4440.
Impact Factor: 5.207
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M
* Molecular imaging of tumor microenvironment (421 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 243-258.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Accardo A, Mansi R, Morisco A, Mangiapia G, Paduano L, Tesauro D, Radulescu A, Aurilio M, Aloj L, Arra C, Morelli G
* Peptide modified nanocarriers for selective targeting of bombesin receptors (373 visite)
Mol Biosyst (ISSN: 1742-206x), 2010 May; 6(5): 878-887.
Impact Factor: 3.825
Dettagli Esporta in BibTeX Esporta in EndNote
Orsi S, De Capua A, Guarnieri D, Marasco D, Netti PA
* Cell recruitment and transfection in gene activated collagen matrix (347 visite)
Biomaterials (ISSN: 0142-9612, 1878-5905electronic, 0142-9612linking), 2010 Jan; 31(3): 570-576.
Impact Factor: 7.883
Dettagli Esporta in BibTeX Esporta in EndNote
Varrone A, Sjoholm N, Eriksson L, Gulyas B, Halldin C, Farde L
* Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT (331 visite) (PDF 244 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Oct; 36(10): 1639-1650.
Impact Factor: 4.531
Dettagli Esporta in BibTeX Esporta in EndNote
Takano A, Gulyas B, Varrone A, Maguire RP, Halldin C
* Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: A rhesus monkey study with (S, S)-[18F]FMeNER-D (341 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36(8): 1308-1314.
Impact Factor: 4.531
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Larobina M, Salvatore M
* Technological platforms for molecular imaging: A vision of the future (377 visite) (PDF 204 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Jun; 21(2): 67-75.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Greco A, Speranza A, Salvatore M
* Ultrasound molecular imaging by targeted microbubble contrast agents (363 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Jun; 21(2): 97-110.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Morisco A, Accardo A, Gianolio E, Tesauro D, Benedetti E, Morelli G
* Micelles derivatized with octreotide as potential target-selective contrast agents in MRI (329 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2009 Mar; 15(3): 242-250.
Impact Factor: 1.807
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Lettieri A, Salvatore M
* Molecular imaging of drug resistance in cancer (404 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Mar; 21(1): 31-36.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Zaccaro L, Del Gatto A, Pedone C, Saviano M
* Peptides for tumour therapy and diagnosis: current status and future directions (630 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2009 Mar; 16(7): 780-795.
Impact Factor: 4.708
Dettagli Esporta in BibTeX Esporta in EndNote
Lucignani G, Salvatore M
* Biotechnology in molecular and cellular imaging (244 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009; 21(1): 1-3.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Gioia M, Monaco S, Van Den Steen PE, Sbardella D, Grasso G, Marini S, Overall CM, Opdenakker G, Coletta M
* The Collagen Binding Domain of Gelatinase A Modulates Degradation of Collagen IV by Gelatinase (378 visite)
J Mol Biol (ISSN: 0022-2836, 1089-8638, 1089-8638electronic), 2009; 386(2): 419-434.
Impact Factor: 3.871
Dettagli Esporta in BibTeX Esporta in EndNote
Brunetti A, Cuocolo A
* European Science Foundation calls for more and better medical imaging research (208 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Sep; 35(9): 1749-1757.
Impact Factor: 4.532
Dettagli Esporta in BibTeX Esporta in EndNote
Pulcrano M, Camera L, Pagano L, Del Vecchio S, Ferone D, Bodei L, Murgia A, Pace L, Storto G, Paganelli G, Colao A, Salvatore M, Lombardi G, Biondi B
* Usefulness of [(111)In-DTPA(0)] octreotide scintigraphy in a family with von Hippel-Lindau disease (331 visite)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2008 Apr; 31(4): 352-359.
Impact Factor: 1.888
Dettagli Esporta in BibTeX Esporta in EndNote
Maggi A, Salvatore M
Molecular imaging (311 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 95-95.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (559 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Grasso G, Fragai M, Rizzarelli E, Spoto G, Yeo KJ
* A new methodology for monitoring the activity of cdMMP-12 anchored and freeze-dried on Au (111) (307 visite)
Journal Of The American Society For Mass Spectrometry (ISSN: 1044-0305), 2007 May; 18(5): 961-969.
Impact Factor: 3.664
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Aurilio M, Rinaldi V, D'Ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, Von Guggenberg E, Joosten L, Sosabowski JK, Breeman WA, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC, De Jong M
* The EEE project (412 visite)
Proc Int Cosm Ray Conf Icrc Universidad Nacional Autonoma De Mexico, 2007; 5(HEPART2): 977-980.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Garibaldi F, Cisbani E, Colilli S, Cusanno F, Fratoni R, Giuliani F, Gricia M, Lucentini M, Fratoni R, Lo Meo S, Magliozzi ML, Santanvenere F, Cinti MN, Pani R, Pellegrini R, Simonetti G, Schillaci O, Del Vecchio S, Salvatore M, Majewski S, Lanza RC, De Vincentis G, Scopinaro F
* Molecular imaging: High-resolution detectors for early diagnosis and therapy monitoring of breast cancer (310 visite)
Nucl Instrum Meth A (ISSN: 0168-9002), 2006 Dec 20; 569(2SPEC.ISS.): 286-290.
Impact Factor: 1.185
Dettagli Esporta in BibTeX Esporta in EndNote
Grasso G, Fragai M, Rizzarelli E, Spoto G, Yeo KJ
* In situ AP/MALDI-MS characterization of anchored matrix metalloproteinases (391 visite)
J Mass Spectrom (ISSN: 1076-5174, 1096-9888), 2006 Dec; 41(12): 1561-1569.
Impact Factor: 2.945
Dettagli Esporta in BibTeX Esporta in EndNote
Del Guerra A, Bartoli A, Belcari N, Herbert D, Motta A, Vaiano A, Di Domenico G, Sabba N, Moretti E, Zavattini G, Lazzarotti M, Sensi L, Larobina M
* Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging (253 visite)
Ieee Transactions On Nuclear Science (ISSN: 0018-9499), 2006 Jun; 53(3): 1078-1083.
Impact Factor: 1.497
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Acampa W, Varrone A, Salvatore M
* Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care (483 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Mar; 33(3): 360-381.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
D'Andrea LD, Del Gatto A, Pedone C, Benedetti E
* Peptide-based molecules in angiogenesis (624 visite)
Chem Biol Drug Des (ISSN: 1747-0277, 1747-0285, 1747-0277linking), 2006 Feb; 67(2): 115-126.
Impact Factor: 2.507
Dettagli Esporta in BibTeX Esporta in EndNote
Grasso G, D'Agata R, Rizzarelli E, Spoto G, D'Andrea LD, Pedone C, Picardi A, Romanelli A, Fragai M, Yeo KJ
* Activity of anchored human matrix metalloproteinase-1 catalytic domain on Au(111) surfaces monitored by ESI-MS (489 visite)
J Mass Spectrom (ISSN: 1076-5174, 1096-9888), 2005 Dec; 40(12): 1565-1571.
Impact Factor: 3.574
Dettagli Esporta in BibTeX Esporta in EndNote
Oliva A, Marrone G, Della Ragione F, Riccio V, Palumbo R, Rossano F, Zappia V
Isolation and characterization of human embryonic osteoblasts (407 visite)
Calcif Tissue Int (ISSN: 0171-967xprint, 0171-967xlinking), 1992 Nov; 51(5): 356-362.
Impact Factor: 2.364
Dettagli Esporta in BibTeX Esporta in EndNote
74 Records (71 escludendo Abstract e Conferenze).
Impact factor totale: 279.944 (273.307 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 232.492 (225.838 escludendo Abstract e Conferenze).
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Ngoc B, Vu Hoa T, N , Palumbo R, Rinaldo P, Fagoonee S, Phuc V
* Stem cell-derived exosomes for wound healing: current status and promising directions (33 visite)
Minerva Med (ISSN: 0026-4806linking), 2021 Jun; 112(3): 384-400.
Impact Factor: 3.031
Dettagli Esporta in BibTeX Esporta in EndNote
Hill BS, Sarnella A, D'Avino G, Zannetti A
* Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer (187 visite) (PDF 38 visite)
Semin Cancer Biol (ISSN: 1044-579xlinking), 2020 Feb; 60: 202-213.
Impact Factor: 11.09
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore B, Caprio MG, Hill BS, Sarnella A, Roviello GN, Zannetti A
* Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer (193 visite) (PDF 82 visite)
Cancers (ISSN: 2072-6694linking), 2019 Oct 22; 11(10): N/D-N/D.
Impact Factor: 6.162
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Stanzione A, Guarino S, Romeo V, Ugga L, Romano F, Storto G, Maurea S, Brunetti A
* Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging (123 visite)
World J Gastroentero (ISSN: 1007-9327linking, 2219-2840), 2019 Sep 21; 25 (35 ): 5233-5256.
Impact Factor: 2.24
Dettagli Esporta in BibTeX Esporta in EndNote
Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH, Bottlaender M, Brooks D, Carroll MA, Chalon S, Gee A, Gerhard A, Halldin C, Herholz K, Herth MM, Hinz R, Knudsen GM, Kuhnast B, López-picón F, Moresco RM, Pappata S, Rinne JO, Rodriguez-vieitez E, Santiago-ribeiro MJ, Turkheimer FE, Van Laere K, Varrone A, Vercouillie J, Winkeler A
* A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies (189 visite)
Alzheimers Dement (ISSN: 1552-5260linking), 2019 Jun 20; N/D: N/D-N/D.
Impact Factor: 14.43
Dettagli Esporta in BibTeX Esporta in EndNote
Mcnitt DH, Choi SJ, Allen JL, Hames RA, Weed SA, Van De Water L, Berisio R, Lukomski S
* Adaptation of the group A Streptococcus adhesin Scl1 to bind fibronectin type III repeats within wound-associated extracellular matrix: implications for cancer therapy (178 visite)
Mol Microbiol (ISSN: 0950-382xlinking), 2019 May 30; N/D: N/D-N/D.
Impact Factor: 3.816
Dettagli Esporta in BibTeX Esporta in EndNote
Perani D, Iaccarino L, Jacobs AH, Lammertsma AA, Nordberg A, Windhorst AD, Gerhard A, Winkeler A, Jacobs AH, Gee A, Kuhnast B, Halldin C, Perani D, Brooks D, Rodriguez-vieitez E, Turkheimer FE, López-picón F, Knudsen GM, Vercouillie J, Rinne JO, Herholz K, Van Laere K, Santiago-ribeiro MJ, Herth MM, Carroll MA, Bottlaender M, Hansson O, Edison P, Hinz R, Boellaard R, Moresco RM, Pappata S
* Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies (233 visite)
Alzheimers Dement (ISSN: 2352-8729print), 2019 Apr 16; 11: 327-332.
Impact Factor: 14.423
Dettagli Esporta in BibTeX Esporta in EndNote
Baroni S, Ruggiero MR, Aime S, Geninatti Crich S
* Exploring the tumour extracellular matrix by in vivo Fast Field Cycling relaxometry after the administration of a Gadolinium-based MRI contrast agent (220 visite)
Magn Reson Chem (ISSN: 0749-1581linking), 2019 Jan 24; N/D: N/D-N/D.
Impact Factor: 1.601
Dettagli Esporta in BibTeX Esporta in EndNote
Squeglia F, Ruggiero A, Berisio R
* Collagen degradation in tuberculosis pathogenesis: the biochemical consequences of hosting an undesired guest (355 visite)
Biochem J (ISSN: 1470-8728electronic, 0264-6021linking, 0264-6021print), 2018 Oct 11; 475(19): 3123-3140.
Impact Factor: 4.897
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Pappata S, Zampella E, Assante R
* Advances in SPECT Methodology (237 visite)
Int Rev Neurobiol (ISSN: 0074-77429780128154182, 2162-5514electronic), 2018 Sep; 141: 77-96.
Impact Factor: 3.36
Dettagli Esporta in BibTeX Esporta in EndNote
Camorani S, Hill BS, Fontanella R, Greco A, Gramanzini M, Auletta L, Gargiulo S, Albanese S, Lucarelli E, Cerchia L, Zannetti A
* Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRbeta Aptamer (629 visite) (PDF 200 visite)
Theranostics (ISSN: 1838-7640, 1838-7640electronic), 2017 Aug 22; 7(14): 3595-3607.
Impact Factor: 8.537
Dettagli Esporta in BibTeX Esporta in EndNote
Longo DL, Stefania R, Aime S, Oraevsky A
* Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications (244 visite)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2017 Aug 7; 18(8): N/D-N/D.
Impact Factor: 3.687
Dettagli Esporta in BibTeX Esporta in EndNote
Gargiulo S, Coda AR, Panico M, Gramanzini M, Moresco RM, Chalon S, Pappata S
* Molecular imaging of neuroinflammation in preclinical rodent models using positron emission tomography (287 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1827-1936), 2017 Mar; 61(1): 60-75.
Impact Factor: 2.368
Dettagli Esporta in BibTeX Esporta in EndNote
Auletta L, Gramanzini M, Gargiulo S, Albanese S, Salvatore M, Greco A
* Advances in multimodal molecular imaging (297 visite)
Q J Nucl Med Mol Imaging, 2017; N/D: N/D-N/D.
Impact Factor: 2.413
Dettagli Esporta in BibTeX Esporta in EndNote
Morbelli S, Arbizu J, Booij J, Chen M-K, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H
* Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 3, (353-357), 10. 1007/s00259-016-3589-9) (175 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2017; 44(3): 559-560.
Impact Factor: 7.704
Dettagli Esporta in BibTeX Esporta in EndNote
Longo DL, Moustaghfir FZ, Zerbo A, Consolino L, Anemone A, Bracesco M, Aime S
* EXCI-CEST: Exploiting pharmaceutical excipients as MRI-CEST contrast agents for tumor imaging (299 visite)
Int J Pharm (ISSN: 0378-5173, 1873-3476), 2017; 525(1): 275-281.
Impact Factor: 3.862
Dettagli Esporta in BibTeX Esporta in EndNote
Gargiulo S, Gramanzini M, Mancini M
* Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models (332 visite) (PDF 181 visite)
Int J Mol Sc (ISSN: 1422-0067, 1661-6596, 1422-0067linking), 2016 Sep 9; 17(9): N/D-N/D.
Impact Factor: 3.226
Dettagli Esporta in BibTeX Esporta in EndNote
Zinnhardt B, Viel T, Wachsmuth L, Vrachimis A, Wagner S, Breyholz HJ, Faust A, Hermann S, Kopka K, Faber C, Dolle F, Pappata S, Planas AM, Tavitian B, Schafers M, Sorokin LM, Kuhlmann MT, Jacobs AH
* Multimodal imaging reveals temporal and spatial microglia and matrix metalloproteinase activity after experimental stroke (291 visite)
J Cerebr Blood F Met (ISSN: 0271-678x), 2015 Nov; 35(11): 1711-1721.
Impact Factor: 4.929
Dettagli Esporta in BibTeX Esporta in EndNote
Longo DL, Arena F, Consolino L, Minazzi P, Geninatti-crich S, Giovenzana GB, Aime S
* Gd-AAZTA-MADEC, an improved blood pool agent for DCE-MRI studies on mice on 1 T scanners (349 visite)
Biomaterials (ISSN: 0142-9612, 1878-5905electronic, 0142-9612linking), 2015 Oct 16; 75: 47-57.
Impact Factor: 8.387
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Gallicchio R, Maddalena F, Pellegrino T, Petretta M, Fiumara G, Cuocolo A
* Estimation of coronary flow reserve by sestamibi imaging in patients with mild hypertension and normal coronary arteries (276 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1827-1936), 2014 Mar 14; 59(3): 336-341.
Impact Factor: 2.033
Dettagli Esporta in BibTeX Esporta in EndNote
Iommelli F, De Rosa V, Fonti R, Del Vecchio S
* Molecular Imaging For Detection Of Sensitivity And Resistance To Egfr Tyrosine Kinase Inhibitors In Non-Small Cell Lung Cancer (259 visite)
Clin Transl Imaging (ISSN: 2281-5872print, 2281-7565online), 2014 Feb 20; 2(1): 43-53.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Petretta A, Pellegrino T, Nappi C, Cantoni V, Cuocolo A
* Nuclear Cardiology in Heart Failure (331 visite)
Curr Cardiovasc Imaging Rep (ISSN: 1941-9066), 2014 Jan; 7(3): 1-7.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Giuffrida ML, Rizzarelli E, Tomaselli GA, Satriano C, Trusso Sfrazzetto G
* A novel fully water-soluble Cu(i) probe for fluorescence live cell imaging (340 visite)
Chem Commun (ISSN: 1359-7345, 1364-548x, 1364-548xelectronic), 2014; 50(69): 9835-9838.
Impact Factor: 6.834
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Greco A, Salvatore G, Liuzzi R, Di Maro G, Vergara E, Chiappetta G, Pasquinelli R, Brunetti A, Salvatore M
* Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice (430 visite)
Bmc Med Imaging (ISSN: 1471-2342, 1471-2342electronic), 2013 Sep 12; 13(1): 31-31.
Impact Factor: 0.983
Dettagli Esporta in BibTeX Esporta in EndNote
Calce E, Monfregola L, De Luca S
* Synthetic Strategy to Prepare DOTA-Based Bifunctional Chelating Agent Ready to Bind Biomolecular Probes (393 visite)
Int J Pept Res Ther (ISSN: 1573-3149, 0929-5666), 2013 Sep; 19(3): 199-202.
Impact Factor: 0.825
Dettagli Esporta in BibTeX Esporta in EndNote
Booij J, Arbizu J, Darcourt J, Hesse S, Nobili F, Payoux P, Pappata S, Tatsch K, Walker Z, Pagani M
* Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine (477 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Jul; 40(7): 1122-1125.
Impact Factor: 5.217
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Fiumara G, Pellegrino T, Zampella E, Assante R, Mainenti PP, Cuocolo A
* MIBG molecular imaging for evaluating response to chemotherapy in patients with malignant pheochromocytoma: preliminary results (235 visite)
Cancer Imaging (ISSN: 1470-7330, 1470-7330electronic, 1470-7330linking), 2013 Apr 15; 13: 155-161.
Impact Factor: 1.286
Dettagli Esporta in BibTeX Esporta in EndNote
Catanzaro V, Gringeri CV, Menchise V, Padovan S, Boffa C, Dastru W, Chaabane L, Digilio G, Aime S
* A R2p/R1p ratiometric procedure to assess matrix metalloproteinase-2 activity by magnetic resonance imaging (341 visite)
Angew Chem Int Ed (ISSN: 1433-7851, 1521-3773electronic), 2013 Apr 2; 52(14): 3926-3930.
Impact Factor: 11.336
Dettagli Esporta in BibTeX Esporta in EndNote
Greco A, Fiumara G, Gargiulo S, Gramanzini M, Brunetti A, Cuocolo A
* High-resolution positron emission tomography/computed tomography imaging of the mouse heart (423 visite)
Exp Physiol Experimental Physiology (ISSN: 1469-445x, 0958-0670), 2013 Mar; 98(3): 645-651.
Impact Factor: 2.871
Dettagli Esporta in BibTeX Esporta in EndNote
D'Agata R, Spoto G
* Surface plasmon resonance imaging for nucleic acid detection (318 visite)
Anal Bioanal Chem (ISSN: 1618-2642), 2013 Jan; 405(2-3): 573-584.
Impact Factor: 3.578
Dettagli Esporta in BibTeX Esporta in EndNote
Petretta M, Cuocolo A
In search of a marker of vulnerable carotid plaque: is the key in the heart? (261 visite)
Atherosclerosis (ISSN: 1879-1484, 0021-9150), 2012 Jul; 223(1): 95-97.
Impact Factor: 3.706
Dettagli Esporta in BibTeX Esporta in EndNote
Jacobs AH, Tavitian B, TheInmindG, Pappata S, Quarantelli M
* Noninvasive molecular imaging of neuroinflammation (314 visite) (PDF 189 visite)
J Cereb Blood Flow Metab (ISSN: 0271-678x, 1559-7016electronic), 2012 Jul; 32(7): 1393-1415.
Impact Factor: 5.398
Dettagli Esporta in BibTeX Esporta in EndNote
Gringeri CV, Menchise V, Rizzitelli S, Cittadino E, Catanzaro V, Dati G, Chaabane L, Digilio G, Aime S
* Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases (440 visite)
Contrast Media Mol Imaging (ISSN: 1555-4309, 1555-4309linking), 2012 Mar; 7(2): 175-184.
Impact Factor: 2.872
Dettagli Esporta in BibTeX Esporta in EndNote
Gargiulo S, Greco A, Gramanzini M, Esposito S, Affuso A, Brunetti A, Vesce G
* Mice Anesthesia, Analgesia, and Care, Part I: Anesthetic Considerations in Preclinical Research (295 visite)
Ilar J (ISSN: 1084-2020, 1930-6180, 1084-2020linking), 2012; 53(1): 55-69.
Impact Factor: 1.582
Dettagli Esporta in BibTeX Esporta in EndNote
Gargiulo S, Greco A, Gramanzini M, Esposito S, Affuso A, Brunetti A, Vesce G
* Mice anesthesia, analgesia, and care, Part II: anesthetic considerations in preclinical imaging studies (284 visite)
Ilar Jilar Journal / National Research Council Institute Of Laboratory Animal Resources (ISSN: 1930-6180, 1084-2020), 2012; 53(1): 70-81.
Impact Factor: 1.582
Dettagli Esporta in BibTeX Esporta in EndNote
Greco A, Mancini M, Gargiulo S, Gramanzini M, Claudio PP, Brunetti A, Salvatore M
* Ultrasound biomicroscopy in small animal research: Applications in molecular and preclinical imaging (419 visite)
J Biomed Biotechnol (ISSN: 1110-7243, 1110-7251), 2012; 2012: 519238-519238.
Impact Factor: 2.88
Dettagli Esporta in BibTeX Esporta in EndNote
Ocak M, Helbok A, Rangger C, Peitl PK, Nock BA, Morelli G, Eek A, Sosabowskijk, Breeman WA, Reubi JC, Decristoforo C
* Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607 (560 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2011 Sep; 38(8): 1426-1435.
Impact Factor: 4.991
Dettagli Esporta in BibTeX Esporta in EndNote
Gulyas B, Vas A, Toth M, Takano A, Varrone A, Cselenyi Z, Schain M, Mattsson P, Halldin C
* Age and disease related changes in the translocator protein (TSPO) system in the human brain: Positron emission tomography measurements with [11C]vinpocetine (528 visite)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2011 Jun 1; 56(3): 1111-1121.
Impact Factor: 5.895
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A
Current research in nuclear medicine and molecular imaging in Italy: Highlights of the 10th National Congress of the Italian Association of Nuclear Medicine and Molecular Imaging (400 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2011 Jun; 55(3): 280-300.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Perrone-filardi P, Dellegrottaglie S, Rudd JH, Costanzo P, Marciano C, Vassallo E, Marsico F, Ruggiero D, Petretta MP, Chiariello M, Cuocolo A
* Molecular imaging of atherosclerosis in translational medicine (489 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 May; 38(5): 969-975.
Impact Factor: 4.991
Dettagli Esporta in BibTeX Esporta in EndNote
Ruggiero A, Squeglia F, Marasco D, Marchetti R, Molinaro A, Berisio R
* X-ray structural studies of the entire extracellular region of the serine/threonine kinase PrkC from Staphylococcus aureus (378 visite)
Biochem J (ISSN: 0264-6021, 1470-8728electronic, 0264-6021linking), 2011 Apr 1; 435(1): 33-41.
Impact Factor: 4.897
Dettagli Esporta in BibTeX Esporta in EndNote
Accardo A, Morisco A, Gianolio E, Tesauro D, Mangiapia G, Radulescu A, Brandt A, Morelli G
* Nanoparticles containing octreotide peptides and gadolinium complexes for MRI applications (460 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2011 Feb; 17(2): 154-162.
Impact Factor: 1.799
Dettagli Esporta in BibTeX Esporta in EndNote
Nardelli A, Castaldi E, Ortosecco G, Speranza A, Storto G, Pace L, Salvatore M
* Enhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90 (402 visite)
Applied Radiation And Isotopes (ISSN: 1872-9800, 0969-8043, 0969-8043linking), 2011 Jan; 69(1): 52-55.
Impact Factor: 1.172
Dettagli Esporta in BibTeX Esporta in EndNote
Morisco A, Accardo A, Tesauro D, Palumbo R, Benedetti E, Morelli G
* Peptide-labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells (346 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2011; 96(1): 88-96.
Impact Factor: 2.87
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M
* Detection of colo-rectal liver metastases: Prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1. 5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents (322 visite)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2010 Oct; 35(5): 511-521.
Impact Factor: 1.95
Dettagli Esporta in BibTeX Esporta in EndNote
D'Andrea LD, Romanelli A, Di Stasi R, Pedone C
* Bioinorganic aspects of angiogenesis (362 visite)
Dalton T (ISSN: 1477-9234, 1477-9226, 1477-9234electronic), 2010 Sep 7; 39(33): 7625-7636.
Impact Factor: 3.647
Dettagli Esporta in BibTeX Esporta in EndNote
Varrone A, Halldin C
Molecular imaging of the dopamine transporter (498 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2010 Sep 1; 51(9): 1331-1334.
Impact Factor: 7.022
Dettagli Esporta in BibTeX Esporta in EndNote
Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A
* In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging (429 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jul; 37(7): 1441-1448.
Impact Factor: 5.036
Dettagli Esporta in BibTeX Esporta in EndNote
Gautier B, Goncalves V, Diana D, Di Stasi R, Teillet F, Lenoir C, Huguenot F, Garbay C, Fattorusso R, D'Andrea LD, Vidal M, Inguimbert N
* Biochemical and Structural Analysis of the Binding Determinants of a Vascular Endothelial Growth Factor Receptor Peptidic Antagonist (420 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2010 Jun 10; 53(11): 4428-4440.
Impact Factor: 5.207
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M
* Molecular imaging of tumor microenvironment (421 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 243-258.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Accardo A, Mansi R, Morisco A, Mangiapia G, Paduano L, Tesauro D, Radulescu A, Aurilio M, Aloj L, Arra C, Morelli G
* Peptide modified nanocarriers for selective targeting of bombesin receptors (373 visite)
Mol Biosyst (ISSN: 1742-206x), 2010 May; 6(5): 878-887.
Impact Factor: 3.825
Dettagli Esporta in BibTeX Esporta in EndNote
Orsi S, De Capua A, Guarnieri D, Marasco D, Netti PA
* Cell recruitment and transfection in gene activated collagen matrix (347 visite)
Biomaterials (ISSN: 0142-9612, 1878-5905electronic, 0142-9612linking), 2010 Jan; 31(3): 570-576.
Impact Factor: 7.883
Dettagli Esporta in BibTeX Esporta in EndNote
Varrone A, Sjoholm N, Eriksson L, Gulyas B, Halldin C, Farde L
* Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT (331 visite) (PDF 244 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Oct; 36(10): 1639-1650.
Impact Factor: 4.531
Dettagli Esporta in BibTeX Esporta in EndNote
Takano A, Gulyas B, Varrone A, Maguire RP, Halldin C
* Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: A rhesus monkey study with (S, S)-[18F]FMeNER-D (341 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36(8): 1308-1314.
Impact Factor: 4.531
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Larobina M, Salvatore M
* Technological platforms for molecular imaging: A vision of the future (377 visite) (PDF 204 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Jun; 21(2): 67-75.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Greco A, Speranza A, Salvatore M
* Ultrasound molecular imaging by targeted microbubble contrast agents (363 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Jun; 21(2): 97-110.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Morisco A, Accardo A, Gianolio E, Tesauro D, Benedetti E, Morelli G
* Micelles derivatized with octreotide as potential target-selective contrast agents in MRI (329 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2009 Mar; 15(3): 242-250.
Impact Factor: 1.807
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Lettieri A, Salvatore M
* Molecular imaging of drug resistance in cancer (404 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Mar; 21(1): 31-36.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Zaccaro L, Del Gatto A, Pedone C, Saviano M
* Peptides for tumour therapy and diagnosis: current status and future directions (630 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2009 Mar; 16(7): 780-795.
Impact Factor: 4.708
Dettagli Esporta in BibTeX Esporta in EndNote
Lucignani G, Salvatore M
* Biotechnology in molecular and cellular imaging (244 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009; 21(1): 1-3.
Impact Factor: 0.268
Dettagli Esporta in BibTeX Esporta in EndNote
Gioia M, Monaco S, Van Den Steen PE, Sbardella D, Grasso G, Marini S, Overall CM, Opdenakker G, Coletta M
* The Collagen Binding Domain of Gelatinase A Modulates Degradation of Collagen IV by Gelatinase (378 visite)
J Mol Biol (ISSN: 0022-2836, 1089-8638, 1089-8638electronic), 2009; 386(2): 419-434.
Impact Factor: 3.871
Dettagli Esporta in BibTeX Esporta in EndNote
Brunetti A, Cuocolo A
* European Science Foundation calls for more and better medical imaging research (208 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Sep; 35(9): 1749-1757.
Impact Factor: 4.532
Dettagli Esporta in BibTeX Esporta in EndNote
Pulcrano M, Camera L, Pagano L, Del Vecchio S, Ferone D, Bodei L, Murgia A, Pace L, Storto G, Paganelli G, Colao A, Salvatore M, Lombardi G, Biondi B
* Usefulness of [(111)In-DTPA(0)] octreotide scintigraphy in a family with von Hippel-Lindau disease (331 visite)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2008 Apr; 31(4): 352-359.
Impact Factor: 1.888
Dettagli Esporta in BibTeX Esporta in EndNote
Maggi A, Salvatore M
Molecular imaging (311 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 95-95.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (559 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Grasso G, Fragai M, Rizzarelli E, Spoto G, Yeo KJ
* A new methodology for monitoring the activity of cdMMP-12 anchored and freeze-dried on Au (111) (307 visite)
Journal Of The American Society For Mass Spectrometry (ISSN: 1044-0305), 2007 May; 18(5): 961-969.
Impact Factor: 3.664
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Aurilio M, Rinaldi V, D'Ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, Von Guggenberg E, Joosten L, Sosabowski JK, Breeman WA, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC, De Jong M
* The EEE project (412 visite)
Proc Int Cosm Ray Conf Icrc Universidad Nacional Autonoma De Mexico, 2007; 5(HEPART2): 977-980.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Garibaldi F, Cisbani E, Colilli S, Cusanno F, Fratoni R, Giuliani F, Gricia M, Lucentini M, Fratoni R, Lo Meo S, Magliozzi ML, Santanvenere F, Cinti MN, Pani R, Pellegrini R, Simonetti G, Schillaci O, Del Vecchio S, Salvatore M, Majewski S, Lanza RC, De Vincentis G, Scopinaro F
* Molecular imaging: High-resolution detectors for early diagnosis and therapy monitoring of breast cancer (310 visite)
Nucl Instrum Meth A (ISSN: 0168-9002), 2006 Dec 20; 569(2SPEC.ISS.): 286-290.
Impact Factor: 1.185
Dettagli Esporta in BibTeX Esporta in EndNote
Grasso G, Fragai M, Rizzarelli E, Spoto G, Yeo KJ
* In situ AP/MALDI-MS characterization of anchored matrix metalloproteinases (391 visite)
J Mass Spectrom (ISSN: 1076-5174, 1096-9888), 2006 Dec; 41(12): 1561-1569.
Impact Factor: 2.945
Dettagli Esporta in BibTeX Esporta in EndNote
Del Guerra A, Bartoli A, Belcari N, Herbert D, Motta A, Vaiano A, Di Domenico G, Sabba N, Moretti E, Zavattini G, Lazzarotti M, Sensi L, Larobina M
* Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging (253 visite)
Ieee Transactions On Nuclear Science (ISSN: 0018-9499), 2006 Jun; 53(3): 1078-1083.
Impact Factor: 1.497
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Acampa W, Varrone A, Salvatore M
* Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care (483 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Mar; 33(3): 360-381.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
D'Andrea LD, Del Gatto A, Pedone C, Benedetti E
* Peptide-based molecules in angiogenesis (624 visite)
Chem Biol Drug Des (ISSN: 1747-0277, 1747-0285, 1747-0277linking), 2006 Feb; 67(2): 115-126.
Impact Factor: 2.507
Dettagli Esporta in BibTeX Esporta in EndNote
Grasso G, D'Agata R, Rizzarelli E, Spoto G, D'Andrea LD, Pedone C, Picardi A, Romanelli A, Fragai M, Yeo KJ
* Activity of anchored human matrix metalloproteinase-1 catalytic domain on Au(111) surfaces monitored by ESI-MS (489 visite)
J Mass Spectrom (ISSN: 1076-5174, 1096-9888), 2005 Dec; 40(12): 1565-1571.
Impact Factor: 3.574
Dettagli Esporta in BibTeX Esporta in EndNote
Oliva A, Marrone G, Della Ragione F, Riccio V, Palumbo R, Rossano F, Zappia V
Isolation and characterization of human embryonic osteoblasts (407 visite)
Calcif Tissue Int (ISSN: 0171-967xprint, 0171-967xlinking), 1992 Nov; 51(5): 356-362.
Impact Factor: 2.364
Dettagli Esporta in BibTeX Esporta in EndNote
74 Records (71 escludendo Abstract e Conferenze).
Impact factor totale: 279.944 (273.307 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 232.492 (225.838 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:15:00
547 views visite. Last view on Ultima visita in data Thursday 10 June 2021, 13:41:41
ibb.cnr.it